CYNVEC

cynvec-logo

Cynvec, an early stage biotech company based in New York City, was created in 2004 through the spin out of exclusively licensed IP from New York University focusing on the utility of the sindbis oncolytic viral vector in the treatment of cancer. It is based on the work of Dr. Daniel Meruelo, Ph.D., the world's leading authority on the virus and professor at NYU. Cynvec is in the process of preparing an investigational new drug application (IND) for our first product, CYN 101.

#People #Website #More

CYNVEC

Industry:
Biotechnology Health Care Medical

Founded:
2004-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.cynvec.com

Total Employee:
1+

Status:
Active

Contact:
+1 (732) 492.1797

Email Addresses:
[email protected]

Total Funding:
2.4 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Wordpress Plugins


Current Employees Featured

not_available_image

Richard Purcell
Richard Purcell President and Chief Operating Officer @ Cynvec
President and Chief Operating Officer

not_available_image

Daniel O Wilds
Daniel O Wilds President & CEO @ Cynvec
President & CEO

steve-blumenthal_image

Steve Blumenthal
Steve Blumenthal Founder @ Cynvec
Founder

Founder


steve-blumenthal_image

Steve Blumenthal

Official Site Inspections

http://www.cynvec.com Semrush global rank: 5.93 M Semrush visits lastest month: 1.39 K

  • Host name: 104.0.153.160.host.secureserver.net
  • IP address: 160.153.0.104
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Cynvec"

Cynvec - Crunchbase Company Profile & Funding

Organization. Cynvec . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Cynvec is a biotechnology company that develops …See details»

Cynvec

Cynvec is an innovative biotechnology company that specializes in developing viral immunotherapies. We are developing a proprietary experimental cancer therapy based on the …See details»

About - Cynvec

The SV vectors transit through the lymph nodes where they also actuate and recruit an immune response to trigger cell death of tumor cells through activated NK cells, macrophages and …See details»

Cynvec Company Profile | Management and Employees List

Cynvec was founded in 2004 to develop and commercialize innovative safe and effective cancer treatments based on intellectual property exclusively licensed from New York University …See details»

Cynvec Company Profile 2024: Valuation, Funding & Investors

Who are Cynvec’s investors? National Institutes of Health, National Cancer Institute, Alexander 2006, and The Litwin Foundation have invested in Cynvec. Data Transparency. Meet our data …See details»

Cynvec - Contacts, Employees, Board Members, Advisors & Alumni …

Cynvec is a biotechnology company that develops a proprietary oncolytic technology for the treatment of cancer. Search Crunchbase ... Products. Resources. Pricing. Resources. Log In. …See details»

Cynvec - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Dec 7, 2015: Venture Round - …See details»

Cynvec LLC - Company Profile and News - Bloomberg Markets

Cynvec LLC is a biotechnology company. The Company develops cancer therapies that target cancer cell types including ovarian, pancreatic, GI, liver, and colorectal. ...See details»

Cynvec LLC Company Profile | New York, NY - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Cynvec LLC of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»

Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive

Nov 11, 2008 Cynvec was founded in 2004 and is a development stage biotech company based in New York City. The Company is focused on developing Sindbis-based viral vectors as …See details»

Cynvec - Overview, News & Similar companies | ZoomInfo.com

Cynvec was founded in 2004 to develop and commercialize innovative safe and effective cancer treatments based on intellectual property exclusively licensed from New York University …See details»

Cynvec - Products, Competitors, Financials, Employees, …

Cynvec is an innovative biotechnology company that specializes in developing viral immunotherapies for cancer treatment. Use the CB Insights Platform to explore Cynvec's full …See details»

Cynvec - Crunchbase

Cynvec is a biotechnology company that develops a proprietary oncolytic technology for the treatment of cancer.See details»

CYN-101 - Drug Targets, Indications, Patents - Synapse - Patsnap

CYN-101: a Apoptosis stimulants Drug, Initially developed by Cynvec LLC, Now, its global highest R&D status is Pending, Mechanism: Apoptosis stimulants, Therapeutic Areas: …See details»

Award - SBIR

Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ... NY-ESO-1,andquot;expressed in …See details»

Research programme: anticancer therapies - Cynvec - AdisInsight

Cynvec is developing follow-on immunotherapeutic vaccine products based on the oncolytic sindbis viral (SV) vector, for the treatment of cancer. This vector ... If your organization has a …See details»

Ovarian Cancer – Cynvec

A large proportion of patients do not successfully respond to platinum-based therapies, and 70–90% of women with ovarian cancer will have a recurrence at some point after their …See details»

Cynvec - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Organization. Cynvec . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 25. ... This year, Cynvec is …See details»

CYN-102 - Drug Targets, Indications, Patents - Synapse - Patsnap

CYN-102, Initially developed by Cynvec LLC, Now, its global highest R&D status is Pending, Therapeutic Areas: Neoplasms,Endocrinology and Metabolic Disease,Urogenital Diseases. ...See details»

Cynvec.com Server IP 160.153.0.104 - IP-Tracker.org

Cynvec.com which uses Public IP Address 160.153.0.104 is actually located in United States (US) in North America, as we mentioned above.. Here are a few IP addresses that are part of the …See details»